J9033 Injection, bendamustine hcl, 1mg
Also known as: bendamustine, Treanda
Intravenous injection of bendamustine hydrochloride, an alkylating agent chemotherapy, dosed per 1 milligram.
In Plain Language
dual-action chemotherapy drug; alkylating cancer agent
Clinical Context
Used to treat chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphomas. Combines alkylating and antimetabolite properties.
RVU Information
CPT J9033 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9033?
CPT J9033 (Injection, bendamustine hcl, 1mg) is a J Codes (Drugs) code. Intravenous injection of bendamustine hydrochloride, an alkylating agent chemotherapy, dosed per 1 milligram.
How is J9033 administered?
CPT J9033 is administered by a healthcare provider, typically via injection or infusion. Used to treat chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphomas. Combines alkylating and antimetabolite properties. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9033 used?
Used to treat chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphomas. Combines alkylating and antimetabolite properties.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.